Trial intelligence / Profile preview

Comparison of Ramosetron Pre-treatment Time for PONV and QTc Prolongation

NCT03278522Phase 4Completed

Sponsor
Konkuk University Medical Center
Start
Jul 2017
Primary completion
Feb 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ramosetron in postoperative nausea and vomiting (PONV), sponsored by Konkuk University Medical Center. Started Jul 2017; status: completed.

02

Drugs

ramosetron
03

Conditions

postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on NCT03278522.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03278522.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call